How would you approach treatment for patients with limited stage small cell lung cancer who, after initial carboplatin/etoposide, develop a new contralateral lung nodule confirmed as SCLC, while their primary tumor shows a partial response?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · Indiana University
Answered on
I assume the scenario is a newly diagnosed LS SCLC in a patient who was appropriately staged with PETCT, brain MRI, etc at time of initial diagnosis. Patient is then treated with definitive chemorads with 4 cycles of platinum/etoposide and xrt. At the time of re staging PETCT, a new contralateral no...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · University of Nebraska Medical Center
Answered on
Since the primary tumor shows only a partial response, I would approach this as relapsed disease, especially if the new lesion develops soon after completion of chemoradiation and while on maintenance durvalumab. If, on the other hand, there has been a long interval between completion of chemoradiat...
Join for free or sign in to see the full answer